Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 32.95% is 153% above its 5-year average of 13.01%, near the high end of its 5-year range (6.99%–32.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.82% above its 12-month average of 29.20%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 32.95%.
DEBT TO ASSETS RATIO
32.95%
DEBT TO ASSETS RATIO AVG TTM
29.20%
DEBT TO ASSETS RATIO AVG 3Y
20.23%
DEBT TO ASSETS RATIO AVG 5Y
13.01%
DEBT TO ASSETS RATIO AVG 10Y
14.49%
DEBT TO ASSETS RATIO AVG 15Y
10.08%
DEBT TO ASSETS RATIO AVG 20Y
7.59%
CURRENT VS TTM AVG
+12.82%
CURRENT VS 3Y AVG
+62.89%
CURRENT VS 5Y AVG
+153.18%
CURRENT VS 10Y AVG
+127.31%
CURRENT VS 15Y AVG
+226.73%
CURRENT VS 20Y AVG
+333.85%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 779 covered companies
CURRENT VS SECTOR MEDIAN
+36508.06%
vs the sector median at left
Myriad Genetics, Inc.
Market Cap
$412.27M
Debt to Assets Ratio
32.95%
TTM Avg
29.20%
3Y Avg
20.23%
5Y Avg
13.01%
Market Cap
$412.94M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.45M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.43M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.21M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$409.02M
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $412.27M | 32.95% | 29.20% | 20.23% | 13.01% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.94M | 0.00% | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $412.60M | 0.03% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $411.45M | 0.10% | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.43M | 0.01% | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $416.21M | 0.02% | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $409.02M | 0.32% | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $417.43M | 0.01% | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $406.96M | 0.19% | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $421.35M | 0.35% | N/A | N/A | N/A |
Debt/Assets
32.9%
Debt/Equity
0.69
Current Ratio
2.21
Interest Coverage
-6.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 32.95% |
| 2026-03-31 | 31.39% |
| 2025-12-31 | 29.69% |
| 2025-09-30 | 29.16% |
| 2025-06-30 | 22.83% |
| 2025-03-31 | 15.66% |
| 2024-12-31 | 13.65% |
| 2024-09-30 | 13.23% |
| 2024-06-30 | 13.21% |
| 2024-03-31 | 13.22% |
| 2023-12-31 | 13.27% |
| 2023-09-30 | 17.53% |
| 2023-06-30 | 17.17% |
| 2023-03-31 | 13.82% |
| 2022-12-31 | 12.10% |
| 2022-09-30 | 11.33% |
| 2022-06-30 | 8.32% |
| 2022-03-31 | 7.16% |
| 2021-12-31 | 6.99% |
| 2021-09-30 | 7.00% |
| 2021-06-30 | 14.75% |
| 2021-03-31 | 16.26% |
| 2020-12-31 | 20.37% |
| 2020-09-30 | 20.19% |
| 2020-06-30 | 20.99% |
| 2020-03-31 | 20.32% |
| 2019-12-31 | 18.79% |
| 2019-09-30 | 18.89% |
| 2019-06-30 | 14.94% |
| 2019-03-31 | 16.91% |
| 2018-12-31 | 17.56% |
| 2018-09-30 | 16.40% |
| 2018-06-30 | 0.79% |
| 2018-03-31 | 5.69% |
| 2017-12-31 | 3.52% |
| 2017-09-30 | 6.04% |
| 2017-06-30 | 8.20% |
| 2017-03-31 | 13.18% |
| 2016-12-31 | 15.99% |
| 2016-09-30 | 15.67% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
